Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Pain syndromes in autosomal dominant polycystic kidney disease

INTRODUCTION

Over 60 percent of patients with autosomal dominant polycystic kidney disease (ADPKD) have abdominal and flank pain [1]. Abdominal pain is typically related to the kidney cysts, but may also be related to liver cysts. Pain may be acute or chronic.

Most patients can be effectively treated, but a minority develop chronic pain that is debilitating [2].

A thorough history provides the best clues to the underlying cause of pain, and radiographic studies are an important adjunct to making the diagnosis. Pain is often not well managed because there is the reflex response of many clinicians to give narcotics for complaints of pain without understanding the etiology.

This topic provides an overview of the pathophysiology and common presentations of pain in ADPKD, and a stepwise approach to its initial management, focusing on pain related to the kidneys.

The general management and the renal and extrarenal manifestations of ADPKD are discussed separately. (See "Course and treatment of autosomal dominant polycystic kidney disease" and "Renal manifestations of autosomal dominant polycystic kidney disease" and "Extrarenal manifestations of autosomal dominant polycystic kidney disease".)

                      

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Aug 2014. | This topic last updated: Dec 4, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Gabow PA. Autosomal dominant polycystic kidney disease--more than a renal disease. Am J Kidney Dis 1990; 16:403.
  2. Hogan MC, Norby SM. Evaluation and management of pain in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17:e1.
  3. Ansell J, Gee W, Bonica J. Diseases of the kidney and ureter. In: Management of Pain, 2nd ed., Bonica J (Ed), Lee & Febiger, Philadelphia 1990. Vol 2, p.1232.
  4. Ammons WS. Renal afferent input to thoracolumbar spinal neurons of the cat. Am J Physiol 1986; 250:R435.
  5. Ammons WS. Bowditch Lecture. Renal afferent inputs to ascending spinal pathways. Am J Physiol 1992; 262:R165.
  6. Nam TS, Baik EJ, Shin YU, et al. Mechanism of transmission and modulation of renal pain in cats; effects of transcutaneous electrical nerve stimulation on renal pain. Yonsei Med J 1995; 36:187.
  7. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329:332.
  8. Gibson P, Watson ML. Cyst infection in polycystic kidney disease: a clinical challenge. Nephrol Dial Transplant 1998; 13:2455.
  9. Ravich L, Lerman PH, Drabkin J. Ruptured renal cyst in polycystic disease. Urology 1976; 7:60.
  10. Carels RA, van Bommel EF. Ruptured giant liver cyst: a rare cause of acute abdomen in a haemodialysis patient with autosomal dominant polycystic kidney disease. Neth J Med 2002; 60:363.
  11. Bajwa ZH, Gupta S, Warfield CA, Steinman TI. Pain management in polycystic kidney disease. Kidney Int 2001; 60:1631.
  12. Delaney VB, Adler S, Bruns FJ, et al. Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis. Am J Kidney Dis 1985; 5:104.
  13. Bennett WM, Elzinga LW, Barry JM. Polycystic kidney disease: II. Diagnosis and management. Hosp Pract (Off Ed) 1992; 27:61.
  14. Ubara Y, Katori H, Tagami T, et al. Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis. Am J Kidney Dis 1999; 34:926.
  15. Tarrass F, Benjelloun M. Acute abdomen caused by spontaneous renal cyst rupture in an ADPKD haemodialysed patient. Nephrology (Carlton) 2008; 13:177.
  16. Chauveau D, Fakhouri F, Grünfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol 2000; 11:1767.
  17. Bajwa ZH, Sial KA, Malik AB, Steinman TI. Pain patterns in patients with polycystic kidney disease. Kidney Int 2004; 66:1561.
  18. Milutinovic J, Fialkow PJ, Agodoa LY, et al. Autosomal dominant polycystic kidney disease: symptoms and clinical findings. Q J Med 1984; 53:511.
  19. Segura JW, King BF, Jowsey SG. Chronic pain and its medical and surgical management in renal cystic diseases. In: Polycystic Kidney Disease, Watson ML, Torres VE (Eds), Oxford University Press, Oxford 1996. p.462.
  20. Grantham JJ, Torres VE, Chapman AB, et al. Volume progression in polycystic kidney disease. N Engl J Med 2006; 354:2122.
  21. Ernst E, Canter PH. The Alexander technique: a systematic review of controlled clinical trials. Forsch Komplementarmed Klass Naturheilkd 2003; 10:325.
  22. Maher CG. Effective physical treatment for chronic low back pain. Orthop Clin North Am 2004; 35:57.
  23. de Mattos AM, Olyaei AJ, Bennett WM. Pharmacology of immunosuppressive medications used in renal diseases and transplantation. Am J Kidney Dis 1996; 28:631.
  24. Henrich WL, Agodoa LE, Barrett B, et al. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis 1996; 27:162.
  25. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272:1845.
  26. Eisenach JC, De Kock M, Klimscha W. alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology 1996; 85:655.
  27. Tryba M, Gehling M. Clonidine--a potent analgesic adjuvant. Curr Opin Anaesthesiol 2002; 15:511.
  28. Smith H, Elliott J. Alpha(2) receptors and agonists in pain management. Curr Opin Anaesthesiol 2001; 14:513.
  29. Dimou P, Paraskeva A, Papilas K, Fassoulaki A. Transdermal clonidine: does it affect pain after abdominal hysterectomy? Acta Anaesthesiol Belg 2003; 54:227.
  30. Goyagi T, Tanaka M, Nishikawa T. Oral clonidine premedication enhances postoperative analgesia by epidural morphine. Anesth Analg 1999; 89:1487.
  31. Lee YH, Lee WC, Chen MT, et al. Acupuncture in the treatment of renal colic. J Urol 1992; 147:16.
  32. Resim S, Gumusalan Y, Ekerbicer HC, et al. Effectiveness of electro-acupuncture compared to sedo-analgesics in relieving pain during shockwave lithotripsy. Urol Res 2005; 33:285.
  33. Osenbach RK, Harvey S. Neuraxial infusion in patients with chronic intractable cancer and noncancer pain. Curr Pain Headache Rep 2001; 5:241.
  34. Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012; 367:2407.